Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis.
Fuhrmann DC, Mondorf A, Beifuß J, Jung M, Brüne B. · 2020
Read Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis. by Fuhrmann DC, Mondorf A, Beifuß J, Jung M, Brüne B. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7452134.txt.
Introduction
Fuhrmann and co-authors study how low oxygen changes iron handling in human macrophages. Iron is vital for cell work, but free iron in excess can harm cells. Under low oxygen, the control system was poorly understood.
Macrophages grown with little oxygen lowered their free iron. They raised ferritin, the iron store protein, including its mitochondrial form. A regulator named NCOA4 fell, which slowed ferritin breakdown. A small RNA and the JNK pathway drove that fall. Ferritin stores then shielded the cells from ferroptosis, an iron-linked cell death. Tumor cells of another type did not show this control loop. The study links iron storage, oxygen levels, and cell death risk in immune cells.
Catalog record
| CREATOR | Fuhrmann DC, Mondorf A, Beifuß J, Jung M, Brüne B. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis By Dominik C Fuhrmann, Antonia Mondorf, Josefine Beifuß, Michaela Jung, Bernhard Brüne Published in: Redox Biology DOI: 10.1016/j.redox.2020.101670 ABSTRACT Abstract Cellular iron, at the physiological level, is essential to maintain several metabolic pathways, while an excess of free iron may cause oxidative damage and/or provoke cell death. Consequently, iron homeostasis has to be tightly controlled. Under hypoxia these regulatory mechanisms for human macrophages are not well understood. Hypoxic primary human macrophages reduced intracellular free iron and increased ferritin expression, including mitochondrial ferritin (FTMT), to store iron. In parallel, nuclear receptor coactivator 4 (NCOA4), a master regulator of ferritinophagy, decreased and was proven to directly regulate FTMT expression. Reduced NCOA4 expression resulted from a lower rate of hypoxic NCOA4 transcription combined with a micro RNA 6862-5p-dependent degradation of NCOA4 mRNA, the latter being regulated by c-jun N-terminal kinase (JNK). Pharmacological inhibition of JNK under hypoxia increased NCOA4 and prevented FTMT induction. FTMT and ferritin heavy chain (FTH) cooperated to protect macrophages from RSL-3-induced ferroptosis under hypoxia as this form of cell death is linked to iron metabolism. In contrast, in HT1080 fibrosarcome cells, which are sensitive to ferroptosis, NCOA4 and FTMT are not regulated. Our study helps to understand mechanisms of hypoxic FTMT regulation and to link ferritinophagy and macrophage sensitivity to ferroptosis. Keywords: Macrophages, Iron, Hypoxia, FTMT, NCOA4, Ferritinophagy, Ferroptosis, miR-6862-5p, JNK INTRODUCTION Iron is critical for Fe–S cluster formation or heme synthesis and thus is essential to maintain the mitochondrial respiratory chain or the citric acid cycle [1,2]. Nevertheless, an excess of free iron may cause severe oxidative damage [3]. Thus, iron import, export, and storage have to be tightly controlled. Under hypoxia, which occurs in tumors or during inflammation, hypoxia inducible factors (HIF) are known to control iron regulatory proteins. HIF-regulated proteins are not only the transferrin receptor (TfR) and the divalent metal transporter 1 (DMT1), which are responsible for iron import, but also ferroportin (FPN), which is the only established iron exporter [[4], [5], [6], [7]]. Iron storage is equally important and may prevent cells from oxidative stress caused by an overload with redox active free iron. In this context three iron storage proteins are known: ferritin heavy chain (FTH), ferritin light chain (FTL), and mitochondrial ferritin (FTMT) [8,9]. FTH and FTL built protein complexes composed of 24 subunits. FTH as well as FTMT carry a ferroxidase activity, which allows storage of ferric hydroxides (Fe3+) instead of reactive ferrous iron (Fe2+) [10]. Iron loading of FTH is mediated by poly(rC)-binding protein 1 (PCBP1) [11]. FTH is regulated at transcriptional, translational, and protein level. Transcription of FTL and FTH under hypoxia or oxidative stress was associated with nuclear factor E2-related factor 2, which binds to antioxidant response elements upstream of the individual genes [12]. Translation of FTH and FTL is under the control of the iron regulatory protein (IRP) machinery. Under conditions of low iron, IRPs bind to an iron response element (IRE) in the 5’ UTR of the ferritin transcripts to block translation [13]. When sufficient iron becomes accessible, IRPs express aconitase activity and do not any longer bind to the IRE, which culminates in enhanced ferritin protein expression [14]. Iron release from ferritins is regulated by a process known as ferritinophagy. Ferritinophagy is mediated by nuclear receptor coactivator 4 (NCOA4), which directly binds FTH and transfers the complex to the autolysosome for degradation [[15], [16], [17], [18]]. NCOA4 has, in contrast to FTH, a low affinity to FTL indicating that ferritinophagy is predominantly regulated via the NCOA4-FTH system [19]. During ferritinophagy stored iron gets released and becomes available for biosynthetic pathways. NCOA4 abundance is controlled by the ubiquitin ligase HERC2 and degraded by the 26S-proteasome [20]. FTMT shows a high sequence homology to FTH, which implies a similar functionality. Nevertheless, mechanisms regulating FTMT are not completely understood. FTMT expression was associated with a shift of iron from the cytosol to mitochondria [21]. Moreover, its expression under hypoxia is HIF-dependent [22]. Macrophages often experience hypoxia, i.e. during inflammation or in the tumor microenvironment. Furthermore, they are known for their central role in iron metabolism, although regulation and functional consequences of macrophage ferritinophagy remains ill-defined [23]. Ferritin expression and ferritinophagy control divergent processes of iron storage vs. release and thus, are supposed to affect cell fate decision. Overexpression of FTMT protected SH-SY5Y neuroblastoma cells from ferroptosis, a form of cell death induced by iron, reactive oxygen species and lipid peroxidation [24,25]. Ferroptosis can be initiated by inhibiting phospholipid hydroperoxide glutathione peroxidase (GPX4) using RSL-3 or by interfering with cellular cystine uptake by Erastin [26,27]. Both inhibitors provoke lipid peroxide accumulation, disturb the GSH/GSSG system and in turn kill cells [28]. Generation of lipid peroxides is supposed to be lipoxygenase-dependent or to occurs as result of Fenton chemistry [29,30]. Fenton chemistry generates highly reactive hydroxyl radicals, which oxidize polyunsaturated fatty acids. GPX4 in turn reduces lipid peroxides and thus, protects from ferroptosis [31]. Besides GPX4, the ferroptosis suppressor protein 1 (FSP1, AIFM2) was shown to reduce CoQ10, which also blocks lipid peroxidation [32,33]. Here we show that an increase of FTMT in hypoxic human macrophages is linked to decreased NCOA4 expression. The NCOA4 decrease results from impaired transcriptional regulation under hypoxia and its mRNA degradation by micro RNA 6862-5p, which is controlled by c-jun N-terminal kinase (JNK). Functionally, an increased FTH and FTMT expression under hypoxia protects macrophages from ferroptosis. MATERIAL AND METHODS Isolation of primary human macrophages 2.1. Primary human macrophages were isolated from Buffy coats using Leucosep tubes (Greiner bio-one, Frickenhausen, Germany) and Biocoll Separating Solution (Biochrom, Berlin, Germany). Cells were washed three times with PBS and were allowed to adhere to 6-well plates, 6 cm dishes, or 48-well plates (Cell+, Sarstedt, Nümbrecht, Germany) for 1 h at 37 °C. Non-adherent cells were removed and remaining monocytes were incubated for at least 7 days with RPMI 1640 medium containing 5% human serum and penicillin/streptomycin. Macrophages were used at a density of approximately 80%. Cell culture HT1080 2.2. HT1080 fibrosarcoma cells were cultured in DMEM medium containing 10% fetal calf serum and penicillin/streptomycin. Cells were seeded 24 h before the experiment to ensure attachment. siRNA transfection 2.3. Primary human macrophages were incubated in RPMI without human serum 16 h prior transfection. Cells were transfected with 50 nM siRNA against NCOA4 (ON-TARGETplus SMART pool, human NCOA4) or 25 nM miR-6862-5p antagomir (miRCURY, Qiagen, Hilden, Germany) using HiPerFect transfection reagent (Qiagen). HT1080 cells were transfected with 8 nM siRNA using jetPrime (Polyplus transfection, Illkirch, France) according to manufacturer's instructions. Treatments 2.4. Cells were treated with SP600125, LY294002, SB203580, AKT VIII, Rapamycin (all from Sigma-Aldrich, Munich, Germany), RSL-3, or Liproxstatin-1 (both from Cayman Chemicals, Ann Arbor, USA) 1 h prior hypoxic incubations. Hypoxic incubations were performed in a SciTive Workstation (Baker Ruskinn, Leeds, UK) at 1% O2 and 5% CO2 for times indicated. Western analysis 2.5. Cells were lysed in a buffer containing 4% SDS, 150 mM NaCl, and 100 mM Tris/HCl, pH 7.4, and sonicated. Protein content was determined by a protein assay kit (Bio-Rad, Munich, Germany) and 60 μg protein were loaded on a 10% SDS gel. Gels were blotted using a Trans Blot Turbo blotting system (Bio-Rad). Before